TY  - GEN
AU  - Holcomb,Bryan
AU  - Yip-Schneider,Michele T
AU  - Matos,Jesus M
AU  - Dixon,Jennifer
AU  - Kennard,Jason
AU  - Mahomed,Julie
AU  - Shanmugam,Rajasubramaniam
AU  - Sebolt-Leopold,Judith
AU  - Schmidt,C Max
TI  - Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies
SN  - 1091-255X
PY  - 2008///0724
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Blotting, Western
KW  - Cell Proliferation
KW  - drug effects
KW  - Chromones
KW  - Curcumin
KW  - Deoxycytidine
KW  - Dose-Response Relationship, Drug
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Electrophoretic Mobility Shift Assay
KW  - Enzyme Inhibitors
KW  - Humans
KW  - MAP Kinase Signaling System
KW  - Morpholines
KW  - NF-kappa B
KW  - Pancreatic Neoplasms
KW  - Proto-Oncogene Proteins c-akt
KW  - Tumor Cells, Cultured
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1007/s11605-007-0406-6
ER  -